Skip to main content
. 2021 Nov 14;27(42):7362–7375. doi: 10.3748/wjg.v27.i42.7362

Table 3.

Baseline laboratory results and treatments of the studied 125 patients


mean ± SD/n (%)
Pulse rate 92 ± 17
Temperature 37 ± 1
Respiratory rate 23 ± 5
Oxygen saturation 93 ± 5
Hemoglobin (gm/dL) 12 ± 2
Platelet count (× 1000/cmm) 183 ± 107
Total leucocyte count (× 1000/cmm) 10 ± 8
Neutrophil : Lymphocyte ratio 1 ± 0
INR 1.16 ± 0.29
PTT 33.9 ± 13.2
Serum creatinine (mg/dL) 1.39 ± 1.43
Serum sodium (mEq/L) 137 ± 9
Serum potassium (mEq/L) 4.18 ± 0.77
Total bilirubin (mg/dL) 3 ± 5
Direct bilirubin (mg/dL) 2.1 ± 3.8
Serum albumin (g/dL) 3.2 ± 0.7
Alanine Transaminase (U/L) 58 ± 53
Aspartate Transaminase (U/L) 92 ± 123
Alkaline phosphatase (U/L) 262 ± 226
Serum ferritin (ng/mL) 667 ± 483
D-dimer (mg/mL) 1560 ± 2503
Fibrinogen (mg/dL) × 100 if presented in g/L 77
Azithromycin 72 (57.6)
Paracetamol 45 (36.0)
Supplementary vitamin C 85 (68.0)
Zinc 69 (55.2)
Colchicine 2 (1.6)
Lactoferrin 18 (14.4)
Other antibiotics 71 (56.8)
Steroids 38 (30.4)
Hydroxyl-chloroquine 29 (23.2)
Low-molecular weight heparin 56 (44.8)
Warfarin 3 (2.4)

PTT: Partial thromboplastin time; INR: International normalized ratio.